Acutaas Chemicals Limited has informed the Exchange about Change in status ofAcutaas Chemicals Electrolytes Private Limited from Wholly owned Subsidiary to Subsidiary ofAcutaas Chemicals Limited

Acutaas Chemicals Electrolytes Private Limited (ACEPL), a wholly owned subsidiary, has allotted 1,111 equity shares to A.R.Z. Pharma Ltd (an Israeli investor) on preferential basis at Rs. 52,490 per share (including Rs. 52,480 share premium). The shares are partly paid-up with 25% called upfront and the remaining 75% due by May 2, 2027. Following this allotment, Acutaas Chemicals Limited's stake in ACEPL reduced from 100% to 90%, causing ACEPL to cease being a wholly owned subsidiary and become a regular subsidiary. The management control of ACEPL remains with the parent company. The number of equity shares held by Acutaas Chemicals in ACEPL remains unchanged at 10,000 shares.